NASDAQ:TLRY (Tilray)
About TLRY
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
Tilray (NASDAQ: TLRY) Latest News

Coronavirus
3 Cannabis Stocks to Buy Ahead of the 3rd-Wave Rebound

Cannabis Stocks
Aphria Is No More! Say Hello to Tilray (NASDAQ:TLRY)

Cannabis Stocks
What the Tilray-Aphria Deal Means for Cannabis Investors

Cannabis Stocks
Aphria Inc (TSX:APHA): Should You Buy the Cannabis Mega-Merger?

Cannabis Stocks
Will Aphria/Tilray Profit From U.S. Weed Legalization?

Cannabis Stocks
Aphria Inc (TSX:APHA) Could Be the Biggest Weed Company as Soon as Next Month

Investing
Aphria (TSX:APHA) Merger Makes it the Biggest Weed Company Now

Stocks for Beginners
Cannabis Stocks Soar Through the Roof: The Next GameStop in the Making?

Cannabis Stocks
Cannabis Melt-Up 2021: Buy Canopy Growth Stock (TSX:WEED) or a Top Peer?

Stocks for Beginners
Why Aphria (TSX:APHA) Stock Soared 35% Last Week

Cannabis Stocks
Cannabis Stocks: A Volatile Week Sees Share Prices Soaring
